NCT06113783View on ClinicalTrials.gov

Assessment of Efficacy of a Single Intra-articular Injection of HYALUBRIX 60 in Knee Osteoarthritis

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 16, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

March 31, 2026

Conditions
Knee Osteoarthritis
Interventions
DEVICE

HYALUBRIX 60

1.5% solution of non-modified HA (60mg/4ml) obtained from bacterial fermentation with high molecular weight.

Trial Locations (1)

00161

RECRUITING

UOC Medicina Fisica e Riabilitativa SMC09, AOU Policlinico Umberto I, Rome, Italy, Roma

Sponsors
All Listed Sponsors
lead

Fidia Farmaceutici s.p.a.

INDUSTRY